Managing medical and psychiatric comorbidity in individuals with major depressive disorder and bipolar disorder

Annals of Clinical Psychiatry

Volumn 24, Issue 2, 2012, Pages 163-169

  McIntyre, Roger S ^a   Rosenbluth, Michael ^b,c   Ramasubbu, Rajamannar ^d   Bond, David J ^d   Taylor, Valerie H ^e   Beaulieu, Serge ^c   Schaffer, Ayal ^f  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO EAST GENERAL HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

Anxiety disorders; Attention deficit hyperactivity disorder; Bipolar disorder; Cardiovascular disease; Comorbidity; Dyslipidemia; Hypertension; Major depressive disorder; Obesity; Personality disorders; Substance use disorders

Indexed keywords

ANXIETY; BIPOLAR DISORDER; COMORBIDITY; DECISION SUPPORT SYSTEM; HEALTH CARE COST; HUMAN; MAJOR DEPRESSION; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SEDENTARY LIFESTYLE; SMOKING; SUICIDAL IDEATION;

BIPOLAR DISORDER; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; EVIDENCE-BASED MEDICINE; HUMANS;

EID: 84865217808     PISSN: 10401237     EISSN: 15473325     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Schaffer A, McIntosh D, Goldstein BI, et al. The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders. Ann Clin Psychiatry. 2012;24:6-22.
2. Bond DJ, Hadjipavlou G, Lam RW, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder. Ann Clin Psychiatry. 2012;24:23-37.
3. Beaulieu S, Saury S, Sareen J, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders. Ann Clin Psychiatry. 2012;24:38-55.
4. Rosenbluth M, MacQueen G, McIntyre RS, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid personality disorders. Ann Clin Psychiatry. 2012;24:56-68.
5. McIntyre RS, Alsuwaidan M, Goldstein BI, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders. Ann Clin Psychiatry. 2012;24:69-81.
6. Ramasubbu R, Beaulieu S, Taylor VH, et al. The CANMAT task force recommendations for the management of patients with mood disorders and comorbid medical conditions: diagnostic, assessment, and treatment principles. Ann Clin Psychiatry. 2012;24:82-90.
7. Ramasubbu R, Taylor VH, Samaan Z, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions. Ann Clin Psychiatry. 2012;24:91-109.
8. Yatham LN, Kennedy SH, Schaffer A, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord. 2009;11:225-255.
9. Kennedy SH, Lam RW, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction. J Affect Disord. 2009;117:S1-S2.
10. McElroy SL, Frye MA, Hellemann G, et al. Prevalence and correlates of eating disorders in 875 patients with bipolar disorder. J Affect Disord. 2011;128:191-198.
11. Harvey AG, Schmidt DA, Scarnà A, et al. Sleep- related functioning in euthymic patients with bipolar disorder, patients with insomnia, and subjects without sleep problems. Am J Psychiatry. 2005;162:50-57. (Pubitemid 40095672)
12. Martín-Merino E, Ruigómez A, Johansson S, et al. Study of a cohort of patients newly diagnosed with depression in general practice: prevalence, incidence, comorbidity, and treatment patterns. Prim Care Companion J Clin Psychiatry. 2010;12:PCC.08m00764.
13. Kessler RC, Merikangas KR, Wang PS. Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century. Annu Rev Clin Psychol. 2007;3:137-158. (Pubitemid 46651124)
14. Mergl R, Seidscheck I, Allgaier AK, et al. Depressive, anxiety, and somatoform disorders in primary care: prevalence and recognition. Depress Anxiety. 2007;24:185-195. (Pubitemid 46789712)
15. McIntyre RS, Keck PE Jr. Comorbidity in bipolar disorder: clinical and research opportunities. Bipolar Disord. 2006;8:645-647. (Pubitemid 44824705)
16. McElroy SL, Altshuler LL, Suppes T, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry. 2001;158:420-426. (Pubitemid 32205199)
17. McElroy SL, Pope HG Jr, Keck PE Jr, et al. Are impulse-control disorders related to bipolar disorder? Compr Psychiatry. 1996;37:229-240. (Pubitemid 26249540)
18. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095-3105. (Pubitemid 37432885)
19. Kessler RC, Rubinow DR, Holmes C, et al. The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychol Med. 1997;27:1079-1089. (Pubitemid 27401831)
20. Stinson FS, Grant BF, Dawson DA, et al. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2005;80:105-116. (Pubitemid 41266966)
21. Simon NM, Otto MW, Wisniewski SR, et al. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2004;161:2222-2229. (Pubitemid 39587287)
22. Angst J, Cui L, Swendsen J, et al. Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication. Am J Psychiatry. 2010;167:1194-1201.
23. Judd LL, Schettler PJ, Akiskal H, et al. Prevalence and clinical significance of subsyndromal manic symptoms, including irritability and psychomotor agitation, during bipolar major depressive episodes. J Affect Disord. 2012;138:440-448.
24. Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007;64:543-552. (Pubitemid 46718287)
25. Merikangas KR, Kalaydjian A. Magnitude and impact of comorbidity of mental disorders from epidemiologic surveys. Curr Opin Psychiatry. 2007;20:353-358. (Pubitemid 46889662)
26. Feinstein AR, Walter SD, Horwitz RI. An analysis of Berkson's bias in case-control studies. J Chronic Dis. 1986;39:495-504. (Pubitemid 16070694)
27. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163:28-40. (Pubitemid 43050100)
28. Kilbourne AM, Cornelius JR, Han X, et al. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord. 2004;6:368-373. (Pubitemid 39345287)
29. Merikangas KR, Zhang H, Avenevoli S, et al. Longitudinal trajectories of depression and anxiety in a prospective community study: the Zurich Cohort Study. Arch Gen Psychiatry. 2003;60:993-1000. (Pubitemid 37222082)
30. Thompson WK, Kupfer DJ, Fagiolini A, et al. Prevalence and clinical correlates of medical comorbidities in patients with bipolar I disorder: analysis of acute-phase data from a randomized controlled trial. J Clin Psychiatry. 2006;67:783-788. (Pubitemid 43946185)
31. McIntyre RS, Kennedy SH, Soczynska JK, et al. Attention-deficit/ hyperactivity disorder in adults with bipolar disorder or major depressive disorder: results from the international mood disorders collaborative project. Prim Care Companion J Clin Psychiatry. 2010;12:pii: PCC.09m00861.
32. Simon GE, Unützer J. Health care utilization and costs among patients treated for bipolar disorder in an insured population. Psychiatr Serv. 1999;50:1303-1308. (Pubitemid 29468533)
33. Krishnan V, Nestler EJ. Linking molecules to mood: new insight into the biology of depression. Am J Psychiatry. 2010;167:1305-1320.
34. Volkow ND, Wang GJ, Telang F, et al. Inverse association between BMI and prefrontal metabolic activity in healthy adults. Obesity (Silver Spring). 2009;17:60-65. (Pubitemid 50310542)
35. Volkow ND, Wise RA. How can drug addiction help us understand obesity? Nat Neurosci. 2005;8:555-560. (Pubitemid 40594193)
36. Volkow N, Li TK. The neuroscience of addiction. Nat Neurosci. 2005;8:1429-1430. (Pubitemid 41573649)
37. McIntyre RS, McElroy SL, Konarski JZ, et al. Substance use disorders and overweight/obesity in bipolar I disorder: preliminary evidence for competing addictions. J Clin Psychiatry. 2007;68:1352-1357. (Pubitemid 47524514)
38. MacKinnon DF, Zandi PP, Cooper J, et al. Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder. Am J Psychiatry. 2002;159:30-35. (Pubitemid 41070723)
39. MacKinnon DF, Xu J, McMahon FJ, et al. Bipolar disorder and panic disorder in families: an analysis of chromosome 18 data. Am J Psychiatry. 1998;155:829-831. (Pubitemid 28252666)
40. MacKinnon DF, McMahon FJ, Simpson SG, et al. Panic disorder with familial bipolar disorder. Biol Psychiatry. 1997;42:90-95. (Pubitemid 27276071)
41. McIntyre RS. Overview of managing medical comorbidities in patients with severe mental illness. J Clin Psychiatry. 2009;70:e17.
42. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998;338:1516-1520. (Pubitemid 28226280)
43. Kupfer DJ. The increasing medical burden in bipolar disorder. JAMA. 2005;293:2528-2530. (Pubitemid 40705735)
44. McIntyre RS, Soczynska JK, Beyer JL, et al. Medical comorbidity in bipolar disorder: re-prioritizing unmet needs. Curr Opin Psychiatry. 2007;20:406-416. (Pubitemid 46889670)
45. Jablensky A, Kendell RE. Criteria for assessing a classification in psychiatry. In: Mai M, Gaebel W, López-Ibor JJ, et al., eds. Psychiatric diagnosis and classification. New York, NY: John Wiley & Sons, Ltd.; 2002:1-24.
46. Costello EJ, Mustillo S, Erkanli A, et al. Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry. 2003;60:837-844. (Pubitemid 36960915)
47. Ferdinand RF, Dieleman G, Ormel J, et al. Homotypic versus heterotypic continuity of anxiety symptoms in young adolescents: evidence for distinctions between DSM-IV subtypes. J Abnorm Child Psychol. 2007;35:325-333. (Pubitemid 46980435)
48. Strakowski SM, DelBello MP, Fleck DE, et al. Effects of co-occurring alcohol abuse on the course of bipolar disorder following a first hospitalization for mania. Arch Gen Psychiatry. 2005;62:851-858. (Pubitemid 41126879)
49. Strakowski SM, DelBello MP, Fleck DE, et al. Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania. Arch Gen Psychiatry. 2007;64:57-64. (Pubitemid 46041739)
50. Mitchell AJ, Vaze A, Rao S. Clinical diagnosis of depression in primary care: a meta-analysis. Lancet. 2009;374:609-619.
51. Hirschfeld RM, Calabrese JR, Weissman MM, et al. Screening for bipolar disorder in the community. J Clin Psychiatry. 2003;64:53-59. (Pubitemid 36182230)
52. Norton PJ, Temple SR, Pettit JW. Suicidal ideation and anxiety disorders: elevated risk or artifact of comorbid depression? J Behav Ther Exp Psychiatry. 2008;39:515-525.
53. Frye MA, Salloum IM. Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations. Bipolar Disord. 2006;8:677-685. (Pubitemid 44824708)
54. Dilsaver SC, Akiskal HS, Akiskal KK, et al. Doseresponse relationship between number of comorbid anxiety disorders in adolescent bipolar/unipolar disorders, and psychosis, suicidality, substance abuse and familiality. J Affect Disord. 2006;96:249-258. (Pubitemid 44827277)
55. Goldberg JF, Singer TM, Garno JL. Suicidality and substance abuse in affective disorders. J Clin Psychiatry. 2001;62:35-43. (Pubitemid 33134510)
56. Waller SJ, Lyons JS, Costantini-Ferrando MF. Impact of comorbid affective and alcohol use disorders on suicidal ideation and attempts. J Clin Psychol. 1999;55:585-595. (Pubitemid 29203341)
57. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry. 2003;54:216-226. (Pubitemid 37270614)
58. Von Korff M, Katon W, Unützer J, et al. Improving depression care: barriers, solutions, and research needs. J Fam Pract. 2001;50:E1.